Records containing: Migraine
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-01-16Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Musculoskeletal Pain(CMP), Chronic Migraine and Cervicogenic Headache
-
CLINICAL_TRIALS study record update · 2026-01-15A Prospective Study on the Effects of Percutaneous Patent Foramen Ovale Closure on Multimodal Brain Function, Cognition, and Emotion in Patients With Migraine and Patent Foramen Ovale
-
CLINICAL_TRIALS study record update · 2026-01-15China HeadAche DIsorders RegiStry
-
CLINICAL_TRIALS study record update · 2026-01-14A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rimegepant for Migraine Prevention in Chinese Participants
-
CLINICAL_TRIALS study record update · 2026-01-14Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate Efficacy and Safety of Eptinezumab for the Preventive Treatment of Migraine
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-14CORRELATE-UK: COnsistency of Response With RimegEpant Oral Lyophilisate in Acute Treatment of migrainE in the United Kingdom
-
CLINICAL_TRIALS study record update · 2026-01-14Interventional, Open-label, Fixed-dose, Long-term Extension Study to Evaluate Safety of Eptinezumab as Preventive Treatment in Patients With Migraine
-
CLINICAL_TRIALS study record update · 2026-01-14Visual Perception in Visual Snow Syndrome
-
CLINICAL_TRIALS study record update · 2026-01-13Safety Profile of High-Frequency Use of a Remote Electrical Neuromodulation (REN) Wearable Device for Migraine Treatment
-
CLINICAL_TRIALS study record update · 2026-01-13AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 3, DOUBLE-BLIND, 3-ARM, STUDY TO INVESTIGATE PAIN RESPONSE WITH INTRANASAL ZAVEGEPANT COMPARED WITH PLACEBO IN THE ACUTE TREATMENT OF MULTIPLE MIGRAINE ATTACKS IN ADULT PARTICIPANTS
-
CLINICAL_TRIALS study record update · 2026-01-09Osmophobia Is Likely the Best Phenotypic Indicator of Migraine: A Prospective, Non-Interventional, 6-Month Longitudinal Study
-
CLINICAL_TRIALS study record update · 2026-01-09Examining the Effectiveness of Basic Body Awareness Therapy in Individuals With Migraine
-
CLINICAL_TRIALS study record update · 2026-01-08Retrospective Cohort Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy
-
CLINICAL_TRIALS study record update · 2026-01-05Combined Effects of Green Light and Transcranial Direct Current Stimulation on Migraine Intensity and Frequency in Migraine Patients.
-
CLINICAL_TRIALS study record update · 2026-01-05Effectivity and Safety of GB20 Acupoint Pharmacopuncture With Lidocaine 2% on Migraine Patients : Study on Head Pain Characteristic and MIDAS-Ina Score
-
CLINICAL_TRIALS study record update · 2025-12-24Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US
-
CLINICAL_TRIALS study record update · 2025-12-23A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Erenumab in Children (6 to < 12 Years) and Adolescents (12 to < 18 Years) With Episodic Migraine (OASIS PEDIATRIC [EM])
-
CLINICAL_TRIALS study record update · 2025-12-22Headache Calm: App-based Breathing Program for Migraine Relief
-
CLINICAL_TRIALS study record update · 2025-12-19A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy, Safety, and Tolerability of Subcutaneous Administration of Fremanezumab Versus Placebo for the Preventive Treatment of Chronic Migraine in Pediatric Patients 6 to 17 Years of Age
-
CLINICAL_TRIALS study record update · 2025-12-19Assessment of the Impact of Headache on the Employee Population of Libbs Pharmaceutical Ltd.
-
CLINICAL_TRIALS study record update · 2025-12-18The Impact of Acupuncture on Biomarkers of Brain Injury and Inflammatory Response in Migraine
-
CLINICAL_TRIALS study record update · 2025-12-16A Phase 4 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens
-
CLINICAL_TRIALS study record update · 2025-12-15The Ubrelvy and Qulipta Pregnancy Exposure Registry EMPRESS: An Observational, Prospective Study to Assess the Safety of Ubrelvy (Ubrogepant) and Qulipta (Atogepant) During Pregnancy
-
CLINICAL_TRIALS study record update · 2025-12-15Development and Evaluation of an AI-empowered Voice-interactive Chatbot for Migraine Management Among Hong Kong Women: a Randomized Crossover Trial
-
CLINICAL_TRIALS study record update · 2025-12-12Intra-Nasal Mechanical Stimulation (INMEST) as a Potential Preventative Treatment for Migraine - A Prospective, Randomized, Open Label, Delayed-Start Study to Evaluate the Safety and Performance of the Walther System